Human-caused Phenomenon or Process – Page 3

Abbott and Dexcom Reach 10-Year Settlement Over Diabetes Sensor Patent Disputes

5 months ago talkbio0Tagged abbott, Continuous glucose monitoring, Dexcom, Diabetes, Legal patent, Litigation, sensor (device), settlement, truce

Abbott, Dexcom, diabetes sensor, patent litigation, settlement, 10-year truce, continuous glucose monitoring (CGM)

Novo Holdings Spearheads $100M Series C Financing for SiteOne Therapeutics to Develop Non-Opioid Pain Therapies

6 months ago talkbio0Tagged Holdings, ion channel modulators, Non-Opioid Pain, Opioid Epidemic, pain chronic management, Peripheral Nervous System, Series C financing, SiteOne Therapeutics

Novo Holdings, SiteOne Therapeutics, Non-opioid pain treatments, Series C financing, Ion channel modulators, Peripheral nervous system (PNS) pain treatments, Chronic pain management, Opioid epidemic

Sandoz Reaches $275 Million Settlement in US Generic Drug Price Fixing Case

6 months ago talkbio0Tagged Antitrust, Drug Industry, drug price fixing, Litigation, sandoz, settlement

Sandoz, generic drug price fixing, settlement, antitrust litigation, pharmaceutical industry

FDA Rejects Full Approval for AstraZeneca’s Andexxa Amid Safety Concerns

6 months ago talkbio0Tagged Andexxa, Approved, AstraZeneca, concerns, F10 wt Allele, Hemorrhage, inhibitors, reversal agent, Safety, United States Food and Drug Administration

Andexxa, AstraZeneca, FDA, full approval, safety concerns, bleeding reversal agent, FXa inhibitors

Reviva’s Brilaroxazine Demonstrates Efficacy and Safety in Long-Term Schizophrenia Treatment

6 months ago talkbio0Tagged Ability to perform cognitive activity, Antipsychotic Agents, Brilaroxazine, Effectiveness, Long-term, Negative, Safety, Schizophrenia, Symptoms aspect

Brilaroxazine, Schizophrenia treatment, Antipsychotic medication, Efficacy and safety, Long-term treatment, Negative symptoms, Cognitive functioning

FDA Halts Pediatric RSV Vaccine Trials Due to Safety Concerns

6 months ago talkbio0Tagged concerns, pediatric trials, Respiratory syncytial virus, Risk, Safety, United States Food and Drug Administration, Vaccines, VAERD

RSV vaccines, pediatric trials, safety concerns, FDA hold, VAERD risk

Keros Therapeutics Faces Major Setback as PAH Trial Dosing Suspended Over Safety Concerns

6 months ago talkbio0Tagged concerns, dosing, KER-012, PAH, Phase II TROPOS trial, Pulmonary arterial hypertension, Safety, Suspensions

Keros Therapeutics, PAH trial, dosing suspension, safety concerns, pulmonary arterial hypertension, cibotercept (KER-012), Phase II TROPOS trial

SIGA’s TPOXX Fails to Demonstrate Efficacy in Treating Mild to Moderate Mpox Cases: STOMP Study Results

6 months ago talkbio0Tagged 3-(2-methoxyphenyl)-5-methoxy-1,3,4-oxadiazol-2(3H)-one, antiviral treatment, Clinical Research, Effectiveness, Safety, Secretory Immunoglobulin A, STOMP, Technology, tecovirimat, Tpoxx

SIGA Technologies, TPOXX, Tecovirimat, Mpox, STOMP Study, Antiviral Treatment, Efficacy, Safety Profile

Moderna’s RSV Vaccines Face Safety Concerns Over Severe Infections in Infants

6 months ago talkbio0Tagged Advisory Committees, concerns, Infant, Moderna, Respiratory syncytial virus, RNA, Messenger, Safety, United States Food and Drug Administration, Vaccines

Moderna, RSV vaccines, safety concerns, severe infections, infants, mRNA vaccines, FDA, advisory committee

Advancements in BTK Inhibitors for Chronic Lymphocytic Leukemia: A Comparative Analysis of AstraZeneca, Eli Lilly, and BeiGene Therapies

6 months ago talkbio0Tagged acalabrutinib, AstraZeneca, BeiGene, Bruton's Tyrosine Kinase Inhibitors [MoA], Chronic Lymphocytic Leukemia, CLL, Continuous therapy, Effectiveness, Eli, Eli Lilly, Fixed-Duration Therapy, ibrutinib, Nemtabrutinib, Pirtobrutinib, Safety, zanubrutinib

BTK inhibitors, Chronic Lymphocytic Leukemia (CLL), AstraZeneca, Eli Lilly, BeiGene, Acalabrutinib, Ibrutinib, Zanubrutinib, Pirtobrutinib, Nemtabrutinib, Fixed-duration therapy, Continuous therapy, Efficacy, Safety